Tilly's (TLYS) Stock Forecast, Price & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tilly's in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" TLYS shares.
View TLYS analyst ratings or view top-rated stocks.

2 brokers have issued twelve-month price objectives for Tilly's' stock. Their TLYS share price forecasts range from $10.50 to $10.50. On average, they predict the company's share price to reach $10.50 in the next year. This suggests a possible upside of 29.3% from the stock's current price.
View analysts price targets for TLYS or view top-rated stocks among Wall Street analysts.

Tilly's' stock was trading at $9.05 on January 1st, 2023. Since then, TLYS stock has decreased by 10.3% and is now trading at $8.12.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, December 7th 2023.
View our TLYS earnings forecast.

Tilly's, Inc. (NYSE:TLYS) announced its quarterly earnings data on Thursday, August, 31st. The specialty retailer reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.21) by $0.17. The specialty retailer earned $159.95 million during the quarter, compared to the consensus estimate of $150.91 million. Tilly's had a negative trailing twelve-month return on equity of 4.47% and a negative net margin of 1.19%. During the same quarter last year, the firm earned $0.13 earnings per share.

Tilly's issued an update on its third quarter 2023 earnings guidance on Friday, September, 1st. The company provided EPS guidance of -$0.11--$0.05 for the period, compared to the consensus earnings per share estimate of -$0.07. The company issued revenue guidance of $166.00 million-$171.00 million, compared to the consensus revenue estimate of $161.90 million.

97 employees have rated Tilly's Chief Executive Officer Edmond Thomas on Glassdoor.com. Edmond Thomas has an approval rating of 71% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tilly's investors own include Pennsylvania Real Estate Investment Trust (PEI), ADMA Biologics (ADMA), CNBX Pharmaceuticals (CNBX), Gran Tierra Energy (GTE), KushCo (KSHB), Organigram (OGI), Zosano Pharma (ZSAN), DHT (DHT), EnLink Midstream (ENLC) and Washington Prime Group (WPG).

Tilly's trades on the New York Stock Exchange (NYSE) under the ticker symbol "TLYS."

Shares of TLYS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TLYS stock can currently be purchased for approximately $8.12.

Tilly's (NYSE:TLYS) has a market capitalization of $243.28 million and generates $672.28 million in revenue each year. The specialty retailer earns $9.68 million in net income (profit) each year or ($0.26) on an earnings per share basis.

The company employs 6,175 workers across the globe.

Tilly's' mailing address is 10 WHATNEY, IRVINE CA, 92618. The official website for the company is www.tillys.com. The specialty retailer can be reached via phone at (949) 609-5599, via email at irelations@tillys.com, or via fax at 949-609-5508.